Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis

被引：15
|
作者：
Zeytinoglu, Meltem [1 ]
Naaman, Sandra C. [2 ]
Dickens, Laura T. [1 ]
机构：
[1] Univ Chicago, Sect Adult & Pediat Endocrinol Diabet & Metab, Dept Med, 5841 South Maryland Ave,AMB M267, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Sect Gen Internal Med, 355 East Grand St, Chicago, IL 60611 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2021年 / 50卷 / 02期
关键词：
Denosumab; Osteoporosis treatment; Antiresorptive therapy; Bone disorders; Sequential therapy; Fracture; SPONTANEOUS VERTEBRAL FRACTURES; POSTMENOPAUSAL WOMEN; ZOLEDRONIC ACID; MINERAL DENSITY; EXPOSURE; RISEDRONATE; EXTENSION; THERAPY; TRIAL; TERIPARATIDE;
D O I：
10.1016/j.ecl.2021.03.004
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：205 / 222
页数：18
相关论文
共 50 条
  • [11] Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
    Sawamura, Masato
    Komatsuda, Atsushi
    Togashi, Masaru
    Wakui, Hideki
    Takahashi, Naoto
    INTERNAL MEDICINE, 2017, 56 (06) : 631 - 636
  • [12] DISCONTINUATION OF STRONTIUM RANELATE OR SWITCHING TO DENOSUMAB IN OSTEOPOROSIS PATIENTS: EFFECTS ON BMD
    Ringe, J. D.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S294 - S294
  • [13] THE INFLUENCE OF DENOSUMAB ON BONE MINERAL DENSITY, STRUCTURAL DAMAGE IN PATIENTS WITH OSTEOPOROSIS AND RHEUMATOID ARTHRITIS
    Dydykina, P.
    Petrova, E.
    Dydykina, I.
    Smirnov, A.
    Glukhova, S.
    Alexeeva, L.
    Nasonov, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1021 - 1021
  • [14] ASSESSING DENOSUMAB'S ROLE IN PREVENTING BONE DENSITY LOSS IN OSTEOPOROSIS PATIENTS ON CORTICOSTEROIDS
    Li, C. R.
    Lee, H. T.
    Deng, Y. L.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 : S214 - S214
  • [15] Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis
    Zhou, Zhenyu
    Chen, Chen
    Zhang, Jun
    Ji, Xinran
    Liu, Lifeng
    Zhang, Guichun
    Cao, Xuecheng
    Wang, Pingshan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2113 - 2122
  • [16] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Ouchi, Yoshimi
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Matsuda, Takayuki
    Kato, Makoto
    Konishi, Eiichi
    Taguchi, Tetsuya
    JOURNAL OF BONE AND MINERAL METABOLISM, 2019, 37 (02) : 301 - 306
  • [17] Effects of denosumab on bone mineral density in Japanese women with osteoporosis treated with aromatase inhibitors for breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Ouchi
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Takayuki Matsuda
    Makoto Kato
    Eiichi Konishi
    Tetsuya Taguchi
    Journal of Bone and Mineral Metabolism, 2019, 37 : 301 - 306
  • [18] CHARACTERISTICS OF 21 HIV PATIENTS WITH OSTEOPOROSIS TREATED WITH DENOSUMAB
    Seow, C. J.
    Hoi, W. H.
    Chew, C. K.
    Dalan, R.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S432 - S432
  • [19] The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis
    Athanasios D. Anastasilakis
    Polyzois Makras
    Stergios A. Polyzos
    Socrates E. Papapoulos
    Calcified Tissue International, 2023, 113 : 469 - 473
  • [20] Impact of Discontinuation of Denosumab on Bone Health in Breast Cancer Patients
    Tannenbaum, Susan
    Soto, Alvaro Alvarez
    Taxel, Pamela
    CANCER RESEARCH, 2024, 84 (09)
12345